IP Library Granted Patent US 9,980,989
Granted Patent B2
US 9,980,989 · App. 14/404,266 · Granted May 29, 2018

Bacterial composition for the treatment of colibacillosis on farms, in particular poultry farms, and also drinking water containing such a bacterial composition

Inventors: Marc De Brueker (Change, FR); Stéphane Thebault (Germain le Fouilloux, FR)
Assignee: NOLIVADE
A61K35/744A23K10/18A23K50/00A23K50/75A23L2/38A23L2/52A61K35/742A61K39/07A61K39/09A23V2002/00A61K2039/52A61K2039/542A61K2039/552A61K2039/70
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,980,989
App. No.
14/404,266
Granted
May 29, 2018
Kind
B2
Abstract

A bacterial composition for the treatment of colibacillosis on farms, in particular poultry farms, contains at least 10 5 cfu/ml of at least one of the following four strains of Bacillus subtilis or of Bacillus licheniformis : NOL01, NOL02, NOL03 and NOL04, and at least 10 5 cfu/ml of at least one lactic acid bacterium chosen from the following lactic acid bacteria: Lactococcus lactis spp lactis 1 strain NOL11 and Pediococcus pentosaceus 2 strain NOL12.

Claims (57)

1. A bacterial composition, comprising at least one strain of Bacillus and at least one lactic acid bacterium, wherein said Bacillus is selected from the group consisting of: NOL01, NOL02, NOL03, and NOL04, and said lactic acid bacterium is selected from the group consisting of: Lactococcus lactis spp lactis 1 strain NOL11 and Pediococcus pentosaceus 2 strain NOL12, wherein said bacterial composition comprises at least about 10 5 cfu/ml of said Bacillus and at least about 10 5 cfu/ml of said lactic acid bacteria.

2. The bacterial composition according to claim 1 , wherein said bacterial composition comprises between 10 5 and 10 9 cfu/ml of said Bacillus and between 10 9 and 10 10 cfu/ml of said lactic acid bacteria.

3. The bacterial composition according to claim 1 , wherein said composition is in sporulated form, in vegetative form, or in a mixture of both sporulated and vegetative form.

4. The bacterial composition according to claim 1 , wherein the composition comprises at least one of the compositions selected from the group consisting of:

the strain NOL 01 and the strain NOL 11;

the strain NOL 01 and the strain NOL 12;

the strain NOL 02 and the strain NOL 11;

the strain NOL 02 and the strain NOL 12;

the strain NOL 03 and the strain NOL 11;

the strain NOL 03 and the strain NOL 12;

the strain NOL 04 and the strain NOL 12; and

the strains NOL 01, NOL 02, NOL 03 and NOL 04, at a concentration from 10 5 to 10 8 cfu/ml and the strains NOL 11 and NOL12 at a concentration from 10 9 to 10 10 cfu/ml.

5. The bacterial composition according to claim 1 , wherein:

the strain NOL 01 is the strain deposited at the Institut Pasteur under the Budapest treaty under the number CNCM I-4606;

the strain NOL 03 is the strain deposited at the Institut Pasteur under the Budapest treaty under the number CNCM I-4607;

the strain NOL 04 is the strain deposited at the Institut Pasteur under the Budapest treaty under the number CNCM I-4608;

the strain NOL 11 is the strain deposited at the Institut Pasteur under the Budapest treaty under the number CNCM I-4609; and

the strain NOL 12 is the strain deposited at the Institut Pasteur under the Budapest treaty under the number CNCM I-4610.

6. A method for treating colibacillosis infections in animal farms, comprising the steps of:

administering to an animal of an effective amount of a bacterial composition, wherein said bacterial composition comprises at least 10 5 cfu/ml of at least one of the strain of Bacillus strains selected from the group consisting of: NOL01, NOL02, NOL03 and NOL04, and at least 10 5 cfu/ml of at least one lactic acid bacterium selected from the group consisting of: Lactococcus lactis spp lactis 1 strain NOL11 and Pediococcus pentosaceus 2 strain NOL12.

7. The method of claim 6 , wherein said bacterial composition comprises between 10 5 and 10 9 cfu/ml of bacillus and between 10 9 and 10 10 cfu/ml of lactic acid bacteria.

8. The method of claim 6 , wherein said bacterial composition is in sporulated form, in vegetative form, or in a mixture of sporulated and vegetative form.

9. The method of claim 6 , wherein said bacterial composition comprises at least one of the compositions selected from the group consisting of:

the strain NOL 01 and the strain NOL 11;

the strain NOL 01 and the strain NOL 12;

the strain NOL 02 and the strain NOL 11;

the strain NOL 02 and the strain NOL 12;

the strain NOL 03 and the strain NOL 11;

the strain NOL 03 and the strain NOL 12;

the strain NOL 04 and the strain NOL 12; and

the strains NOL 01, NOL 02, NOL 03 and NOL 04, at a concentration from 10 5 to 10 8 cfu/ml and the strains NOL 11 and NOL12 at a concentration from 10 9 to 10 10 cfu/ml.

10. The method of claim 6 , wherein:

the strain NOL 01 is the strain deposited at the Institut Pasteur under the Budapest treaty under the number CNCM I-4606;

the strain NOL 03 is the strain deposited at the Institut Pasteur under the Budapest treaty under the number CNCM I-4607;

the strain NOL 04 is the strain deposited at the Institut Pasteur under the Budapest treaty under the number CNCM I-4608;

the strain NOL 11 is the strain deposited at the Institut Pasteur under the Budapest treaty under the number CNCM I-4609; and

the strain NOL 12 is the strain deposited at the Institut Pasteur under the Budapest treaty under the number CNCM I-4610.

11. The method of claim 6 , wherein the animal farm is a poultry farm.

12. The method of claim 6 , further comprising the step of: adding said bacterial composition to a drinking water.

13. A drinking water for a farm animal, comprising:

an effective amount of water; and

a bacterial composition, comprising at least 10 5 cfu/ml of at least one Bacillus selected from the group consisting of: NOL01, NOL02, NOL03 and NOL04; and at least 10 5 cfu/ml of at least one lactic acid bacterium selected from the group consisting of: Lactococcus lactis spp lactis 1 strain NOL11 and Pediococcus pentosaceus 2 strain NOL12.

14. The drinking water according to claim 13 , wherein said bacterial composition comprises at least one of the compositions selected from the group consisting of:

the strain NOL 01 and the strain NOL 11;

the strain NOL 01 and the strain NOL 12;

the strain NOL 02 and the strain NOL 11;

the strain NOL 02 and the strain NOL 12;

the strain NOL 03 and the strain NOL 11;

the strain NOL 03 and the strain NOL 12;

the strain NOL 04 and the strain NOL 12; and

the strains NOL 01, NOL 02, NOL 03 and NOL 04, at a concentration from 10 5 to 10 8 cfu/ml and the strains NOL 11 and NOL12 at a concentration from 10 9 to 10 10 cfu/ml.

15. The drinking water according to claim 13 , wherein:

the strain NOL 01 is the strain deposited at the Institut Pasteur under the Budapest treaty under the number CNCM I-4606;

the strain NOL 03 is the strain deposited at the Institut Pasteur under the Budapest treaty under the number CNCM I-4607;

the strain NOL 04 is the strain deposited at the Institut Pasteur under the Budapest treaty under the number CNCM I-4608;

the strain NOL 11 is the strain deposited at the Institut Pasteur under the Budapest treaty under the number CNCM I-4609; and

the strain NOL 12 is the strain deposited at the Institut Pasteur under the Budapest treaty under the number CNCM I-4610.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2022
From: NOLIVADE
To: MIXSCIENCE
Reel/Frame 059608/0132 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 6, 2015
From: DE BRUEKER, MARC; THEBAULT, STEPHANE
To: NOLIVADE
Reel/Frame 034910/0773 →
Priority Claims (1)
FR 12 54976 · May 30, 2012 · national
Continuity (1)
Related Publication 20150250832A1 · Sep 10, 2015